Caprelsa 300MG (1 BT)
Ended Awarded
- Contract number
- VA25612F2146
- Awardee
-
Astrazeneca LIMITED Partnership UEI FBWCB39K5929
- Awarding agency
-
Veterans Integrated Service Network 16
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $7,335
Award facts
- Contract value 100% obligated
- $7,334.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Cary, NC 27513, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract VA25612F2146?
VA25612F2146 was awarded to Astrazeneca LIMITED Partnership by Veterans Integrated Service Network 16 (Veterans Health Administration) on August 14, 2012.
How much is contract VA25612F2146 worth?
The government has obligated $7,335 on VA25612F2146.
Is contract VA25612F2146 an order under another contract?
Yes. VA25612F2146 is a BPA call under V797P2211D-VA797P12A0007, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract VA25612F2146 competed?
The extent of competition for VA25612F2146 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award